Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CVS Health Corp (CVS) vs Freshworks Inc (FRSH) Price & Performance

CVS Health CorpTrade
Freshworks IncTrade

Price performance (Past 24H)

Key statistics

CVS Health Corp vs Freshworks Inc — how do they compare? CVS Health Corp trades at $86.2 (market cap $112.49B), while Freshworks Inc trades at $13.58 (market cap $3.55B). The key difference: CVS Health Corp is far larger — about 31.7× Freshworks Inc's market cap, and CVS Health Corp pays a 3.02% dividend while Freshworks Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Freshworks Inc for 39 Days on average.

CVSFRSH
Market Cap
$112.49B$3.55B
Volume
8,467,39247,552,028
Sector
HealthTechnology
52-Week High
$110.60$13.92
52-Week Low
$70.08$6.88
Typical Hold Time
83 Days39 Days
Enterprise Value
$174.83B$2.92B
Dividend Yield
3.02%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CVS Health Corp

CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.

CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.

Freshworks Inc

Freshworks (FRSH) trades at $13.64, down 0.87% on the day, amid a bullish technical setup and strong fundamental progress. The company achieved its first quarter of GAAP profitability in Q2 2026, with revenue growth of 16% year-over-year, and maintains a high gross profit margin of 84.96%. Analyst sentiment is evenly split between Buy and Hold, with a consensus price target of $14.60, suggesting modest upside from current levels.

The outlook for FRSH is positive, driven by sustained revenue growth, improving profitability, and strategic focus on AI and enterprise markets. Key risks include high valuation multiples like an EV/EBITDA of 43.78 and competitive pressures in the SaaS sector. The stock presents an opportunity for investors seeking exposure to a growing, profitable software company, but requires monitoring of execution against elevated expectations.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CVS

No sentiment data available yet.

FRSH
0% Buy100% Sell
Avg holding period · 39 Days

Top news

Latest headlines on both assets

About CVS Health Corp

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

Read more on CVS →

About Freshworks Inc

Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CX and ITSM categories, and have also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and better serve their customers and employees.

Read more on FRSH →